238 related articles for article (PubMed ID: 28589433)
1. Overexpression of dishevelled 2 is involved in tumor metastasis and is associated with poor prognosis in hepatocellular carcinoma.
Zhang C; Li C; Chen X; Zhou Y; Yin B; Ni R; Zhang Y; Liu J
Clin Transl Oncol; 2017 Dec; 19(12):1507-1517. PubMed ID: 28589433
[TBL] [Abstract][Full Text] [Related]
2. The suppressor of cytokine signaling 2 (SOCS2) inhibits tumor metastasis in hepatocellular carcinoma.
Cui M; Sun J; Hou J; Fang T; Wang X; Ge C; Zhao F; Chen T; Xie H; Cui Y; Yao M; Li J; Li H
Tumour Biol; 2016 Oct; 37(10):13521-13531. PubMed ID: 27465557
[TBL] [Abstract][Full Text] [Related]
3. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity.
Wu XS; Bao TH; Ke Y; Sun DY; Shi ZT; Tang HR; Wang L
Tumour Biol; 2016 Nov; 37(11):14711-14719. PubMed ID: 27623945
[TBL] [Abstract][Full Text] [Related]
4. CYP2E1 plays a suppressive role in hepatocellular carcinoma by regulating Wnt/Dvl2/β-catenin signaling.
Zhu L; Yang X; Feng J; Mao J; Zhang Q; He M; Mi Y; Mei Y; Jin G; Zhang H
J Transl Med; 2022 May; 20(1):194. PubMed ID: 35509083
[TBL] [Abstract][Full Text] [Related]
5. Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.
Lei X; Li YF; Chen GD; Ou DP; Qiu XX; Zuo CH; Yang LY
Oncotarget; 2015 Dec; 6(38):40622-41. PubMed ID: 26536663
[TBL] [Abstract][Full Text] [Related]
6. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
7. miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F.
Luo G; Chao YL; Tang B; Li BS; Xiao YF; Xie R; Wang SM; Wu YY; Dong H; Liu XD; Yang SM
Oncotarget; 2015 Nov; 6(35):37808-23. PubMed ID: 26498692
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of paraoxonase 3 contributes to aggressive human hepatocellular carcinoma progression and associates with poor prognosis.
Jin Y; Li Q; Qiu J; Zhao X; Zheng C; Lv S; Bai Y; Shan Y; Ye LC
Tumour Biol; 2016 Oct; 37(10):14193-14203. PubMed ID: 27553024
[TBL] [Abstract][Full Text] [Related]
9. Suppression of the nuclear transporter-KPNβ1 expression inhibits tumor proliferation in hepatocellular carcinoma.
Yang L; Hu B; Zhang Y; Qiang S; Cai J; Huang W; Gong C; Zhang T; Zhang S; Xu P; Wu X; Liu J
Med Oncol; 2015 Apr; 32(4):128. PubMed ID: 25794490
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Dishevelled-2 contributes to proliferation and migration of human esophageal squamous cell carcinoma.
Zhou G; Ye J; Sun L; Zhang Z; Feng J
J Mol Histol; 2016 Jun; 47(3):287-95. PubMed ID: 27083564
[TBL] [Abstract][Full Text] [Related]
11. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
13. High expression of TRIM44 is associated with enhanced cell proliferation, migration, invasion, and resistance to doxorubicin in hepatocellular carcinoma.
Zhu X; Wu Y; Miao X; Li C; Yin H; Yang S; Lu X; Liu Y; Chen Y; Shen R; Chen X; He S
Tumour Biol; 2016 Nov; 37(11):14615-14628. PubMed ID: 27619678
[TBL] [Abstract][Full Text] [Related]
14. Decreased Expression of EHD2 Promotes Tumor Metastasis and Indicates Poor Prognosis in Hepatocellular Carcinoma.
Liu J; Ni W; Qu L; Cui X; Lin Z; Liu Q; Zhou H; Ni R
Dig Dis Sci; 2016 Sep; 61(9):2554-67. PubMed ID: 27221498
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
[TBL] [Abstract][Full Text] [Related]
16. The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target.
Chen DT; Pan JH; Chen YH; Xing W; Yan Y; Yuan YF; Zeng WA
Br J Anaesth; 2019 Jun; 122(6):e157-e167. PubMed ID: 30915986
[TBL] [Abstract][Full Text] [Related]
17. High Expression of Neuropilin-1 Associates with Unfavorable Clinicopathological Features in Hepatocellular Carcinoma.
Zhang Y; Liu P; Jiang Y; Dou X; Yan J; Ma C; Fan Q; Wang W; Su F; Tang H; Su X
Pathol Oncol Res; 2016 Apr; 22(2):367-75. PubMed ID: 26563279
[TBL] [Abstract][Full Text] [Related]
18. SET7/9 promotes hepatocellular carcinoma progression through regulation of E2F1.
Gu Y; Wang X; Liu H; Li G; Yu W; Ma Q
Oncol Rep; 2018 Oct; 40(4):1863-1874. PubMed ID: 30106440
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA CARLo-5 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.
Wang F; Xie C; Zhao W; Deng Z; Yang H; Fang Q
Clin Exp Med; 2017 Feb; 17(1):33-43. PubMed ID: 26433964
[TBL] [Abstract][Full Text] [Related]
20. S100A14 promotes the growth and metastasis of hepatocellular carcinoma.
Zhao FT; Jia ZS; Yang Q; Song L; Jiang XJ
Asian Pac J Cancer Prev; 2013; 14(6):3831-6. PubMed ID: 23886191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
